Pfizer's charity backs infectious disease projects

Caroline Roan, president of the Pfizer Foundation (Concordia)

The Pfizer Foundation has awarded 20 grants to organizations involved in tackling infectious diseases in low- and middle-income countries.

Pfizer set up the foundation to promote access to healthcare and nurture innovation. As part of that focus, the nonprofit has selected 20 organizations in 12 countries to receive one-year grants worth $100,000, resulting in a total outlay of $2 million.

The recipients of the grants are involved in tackling infectious diseases, including initiatives to stem the rise of organisms resistant to antimicrobials. That focus reflects the nonprofit’s assessment of the biggest healthcare priorities in low and middle-income countries and beyond

Featured Webinar

From Concept to Market: Overcoming the Challenges of Manufacturing and Clinical Trials

In this webinar we will reveal the inner workings of the manufacturing and pharmacy department of a CRO/CDMO, so you understand the different regulatory and operational considerations faced by a clinical research pharmacy.

Learn how CRO/CDMOs successfully address operational and regulatory challenges for pharmaceutical and biotechnology clients; and how this can make the difference between study success or failure.

“Mounting infectious disease outbreaks and the threat of large-scale antimicrobial resistance are increasingly becoming some of the most challenging global health needs of our time,” Caroline Roan, president of the Pfizer Foundation, said in a statement. “We are dedicated to working with individuals and organizations in local communities as they rethink and scale innovative solutions to fight infectious diseases from the ground up.”

In disclosing the news, the Pfizer Foundation picked out a clinical staff training program in Mali, introduction of a colonoscope in India and development of a Nepalese antimicrobial resistance education program as examples of the grant recipients.

With the financial commitments, the Pfizer Foundation brought total funding provided through its global health innovation grants up to $7.5 million. The foundation introduced the grants in 2016 and claims the program has resulted in care for 370,000 new patients and the training of 2,000 health workers. 

In providing the funding and technical support that drove those outcomes, the Pfizer Foundation has worked with Innovations in Healthcare (IiH), a nonprofit hosted by Duke University. IiH and the foundation manage the health innovation grant program together and jointly analyze the results generated by each of the supported programs. 

Suggested Articles

Xevinapant in combination with standard cisplatin-based chemoradiation therapy (CRT) reduces the risk of death in high-risk patients with locally adva

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.